Nuria Cirauqui Díaz

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Fármacos e Medicamentos

ORCID:

não disponível no Lattes


Formação:
  • Ecole Polytechnique Fédérale de Lausanne

    | Pós-Doutorado | 2015 - 2016
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2009 - Agora
  • Universidad de Navarra

    Desenho, síntese e evacuação biológica de fármacos | Doutorado | 2004 - 2009
  • Universidad de Navarra

    Química | Graduação | 1999 - 2004
Laboratórios:
Nuvens de Palavras:
Artigos:

(72.73% artigos com DOI)

Titulo DOI Ano
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 10.1016/j.ejmech.2018.12.005 2019
Second Generation of Mannich Base-Type Derivatives with Activity against 10.1021/acs.jmedchem.8b00468 2018
Mapping the sensing spots of aerolysin for single oligonucleotides analysis 10.1038/s41467-018-05108-5 2018
BK polyomavirus genotypes Ia and Ib1 exhibit different biological properties in renal transplant recipients 10.1016/j.virusres.2017.10.018 2018
Structural, physicochemical and dynamic features conserved within the aerolysin pore-forming toxin family 10.1038/s41598-017-13714-4 2017
Phylogenetic and structural analysis of merkel cell polyomavirus VP1 in Brazilian samples 10.1016/j.virusres.2016.05.004 2016
Design, Synthesis and Evaluation of New Fluoroamodiaquine Analogues 10.1248/cpb.c15-01001 2016
Cryo-EM structure of aerolysin variants reveals a novel protein fold and the pore-formation process 10.1038/ncomms12062 2016
In Vitro and in Vivo Anti- Activity of New Arylamine Mannich Base-Type Derivatives 10.1021/acs.jmedchem.6b00784 2016
Analysis of worldwide sequence mutations in Zika virus proteins E, NS1, NS3 and NS5 from a structural point of view 10.1039/c6mb00645k 2016
Molecular modeling study of a series of amodiaquine analogues with antimalarial activity 10.1007/s00044-015-1403-z 2015
Genetic and structural analysis of polyomavirus BK T-antigens reveal a higher density of mutations at inter-domain and hexamerization regions, regardless the status of infection 10.1002/jmv.24192 2015
Genetic and Structural Analysis of Merkel Cell Polyomavirus Large T Antigen from Diverse Biological Samples 10.1159/000363241 2014
Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies 10.1016/j.ejmech.2012.02.049 2012
Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents 10.1016/j.bmc.2010.09.014 2010
New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity 2008
Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity 2008
New biphenylmethyl urea derivatives as MCH-R1 and H3 receptors antagonists for the treatment of obesity 2008
Synthesis and biological evaluation of new urea derivatives targeting the MCH-R1 and histamine H3 receptors for the treatment of obesity 2008
Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity 10.1016/j.bmc.2007.02.049 2007
Synthesis and biological evaluation of arylamide derivatives as melanin-concentrating hormone receptor 1 antagonists 2006
Arylsulfonamide derivatives as melanin-concentrating hormone receptor 1 antagonists 2006
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
In silico study of the binding of sulfonylurea drugs to its receptor SUR1 2014
Functional Characterization of ?Two Hybrid Associated Protein 1 with RanBPM? (Twa1), a New Nuclear Protein Related to Cancer 2012
Building of a MCHR1 homology model provides insight into the protein-drug contacts important for the development of new antiobesity agents 2008
Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity 2007
Arylsulfonamide and arylamide derivatives as MCHR1 antagonists for the treatment of obesity 2007
Synthesis and biological evaluation of new urea derivatives as MCH-R1 antagonists for the treatment of obesity 2007
Sulfonamides and Sulfonyl derivatives as potential anti-cancer agents 2006
Arylsulfonamide derivatives as melanin-concentrating hormone receptor 1 antagonists 2006
Synthesis and biological evaluation of arylamide derivatives as melanin-concentrating hormone receptor 1 antagonists 2006
Síntesis y evaluación biológica de nuevos derivados de arilsulfonamidometilfenilo como antagonistas NPY HY5 para el tratamiento de la obesidad 2005
Síntesis y evaluación biológica preliminar de nuevos derivados de 4-yodofenilcarbohidrazida como antagonistas del receptor Y5 del neuropéptido Y 2005
Publicações:
Minha Rede: